Anticardiolipin antibodies in diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy.
El-Diasty
Amany M
AM
Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Shahin
Maha
M
D000328:Adult; D000368:Aged; D017153:Antibodies, Anticardiolipin / Q000097:blood*; D001794:Blood Pressure; D003920:Diabetes Mellitus / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood; D003930:Diabetic Retinopathy / Q000097:blood* / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood / Q000276:immunology; D007075:Immunoglobulin M / Q000097:blood / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D055815:Young Adult
D017153:Antibodies, Anticardiolipin; D006442:Glycated Hemoglobin; D007074:Immunoglobulin G; D007075:Immunoglobulin M